Colonoscopy's carbon footprint under the microscope
NCT ID NCT07171853
First seen Jun 24, 2026 · Last updated Aug 05, 2026 · Updated 3 times
Summary
This study measures the carbon dioxide emissions produced during colonoscopy for colorectal cancer screening, including energy use, equipment, medications, and waste. Researchers will also compare different polypectomy techniques to see which are more eco-friendly. The goal is to establish baseline data and identify ways to reduce the environmental impact of this common procedure.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help hospitals adopt greener practices for colonoscopy, reducing the carbon footprint of routine cancer screening.
- What could go wrong
- This is an observational study measuring emissions, not testing a treatment. The findings may not apply to all hospitals or regions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
362 people
The number who actually took part.
- Started
-
Oct 2025
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients aged 18-80 years who received a colonoscopy at King Chulalongkorn Memorial Hospital
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 18-80 years Exclusion Criteria: * Patient status grade III-V according to the American Society of Anesthesiologists (ASA) * Poor bowel preparation (grade \<6 in the Boston Bowel Preparation Scale \[BBPS\]) * Endoscopic JNET type III or suspicion of malignancy * Hematologic or coagulation disorders, Plt\<140,000/mcL, INR\>1.5 * anti-platelet/anticoagulant medication that could not be paused as recommended in the current guideline * Emergency colonoscopy, GI bleeding, unstable vital sign, critical ill patient * Inflammatory bowel disease * Pregnancy * Severe cardiopulmonary disease * Severe infection * Malignancy * History of allergy to IV sedative medication
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colonoscopy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
King Chulalongkorn Memorial Hospital
Bangkok, Bangkok, 10330, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a lab test tell which chemo works for colon cancer?
- Warm water may make colonoscopy less painful for older adults
- Can MRI and computer models predict how well cancer drugs reach tumors?
- Gut bacteria may hold clues to why some cancer treatments work better
- Burning the edges: a new way to stop colon polyps from coming back
- Missed Follow-Up colonoscopies: do they raise the risk of advanced growths?